Table 3

Relation between number of antianginal drugs, frequency of pain, and dyspnoea grade with mean (SD) domain scores in four year survivors of myocardial infarction—univariate analysis

Physical functioningRole physicalBodily painGeneral healthVitalitySocial functioningEmotional roleMental health
Number of antianginal drugs
0 (n = 151)57.8 (32.5)58.6 (45.0)64.3 (29.2)55.2 (24.4)53.0 (22.6)75.2 (29.0)71.1 (42.0)72.5 (18.6)
 1 (n = 179)56.0 (32.8)49.8 (44.9)64.5 (29.9)51.9 (23.2)49.1 (23.1)72.7 (30.4)66.8 (42.0)72.4 (20.1)
 2 (n = 55)45.3 (33.7)50.0 (48.7)54.6 (27.5)41.8 (21.7)42.0 (22.8)64.4 (31.0)63.9 (43.5)64.8 (16.6)
 3 (n = 16)42.9 (22.4)32.1 (45.4)54.5 (26.7)42.8 (26.2)41.3 (25.1)64.4 (31.0)63.9 (43.5)64.8 (16.6)
 p value0.0550.7190.0910.0070.0220.0560.9410.039
Episodes of chest pain (per week)
 < 1 (n = 43)53.0 (25.4)53.1 (43.9)65.8 (24.1)50.8 (23.8)54.2 (17.9)74.1 (29.1)65.8 (42.4)71.9 (19.2)
 1 or 2 (n = 57)39.7 (25.1)27.9 (40.4)50.8 (17.7)37.4 (17.9)39.6 (19.9)62.9 (27.7)56.9 (42.6)68.2 (19.5)
 ⩾ 3 (n = 52)28.9 (24.8)17.6 (33.8)40.0 (20.7)32.2 (17.7)29.5 (22.0)52.9 (29.7)58.1 (43.1)62.0 (22.3)
 p value< 0.001< 0.001< 0.001< 0.001< 0.0010.0020.5480.096
Dyspnoea score
 No dyspnoea (n = 152)73.6 (29.7)73.9 (40.3)75.2 (27.8)65.8 (19.6)60.8 (20.8)83.1 (25.5)82.6 (34.6)75.7 (17.9)
 Grade 1 (n = 73)61.7 (25.2)56.9 (43.0)66.1 (28.5)55.8 (21.8)54.7 (17.4)83.1 (20.7)73.7 (38.4)77.0 (16.5)
 Grade ⩾ 2 (n = 163)35.1 (26.2)29.0 (40.5)50.5 (25.0)37.3 (19.7)37.7 (21.0)58.9 (30.7)53.3 (44.4)65.7 (20.2)
 p value< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001